244 related articles for article (PubMed ID: 33361598)
1. Ameliorating Ribosylation-Induced Amyloid-β Pathology by Berberine via Inhibiting mTOR/p70S6K Signaling.
Wang YY; Yan Q; Huang ZT; Zou Q; Li J; Yuan MH; Wu LQ; Cai ZY
J Alzheimers Dis; 2021; 79(2):833-844. PubMed ID: 33361598
[TBL] [Abstract][Full Text] [Related]
2. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
Cai Z; Wang C; He W; Chen Y
Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
[TBL] [Abstract][Full Text] [Related]
3. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y
Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223
[TBL] [Abstract][Full Text] [Related]
4. [Effect of moxibustion on autophagy in mice with Alzheimer's disease based on mTOR/p70S6K signaling pathway].
Wu YY; Song XG; Zhu CF; Cai SC; Ge X; Wang L; Jia YM
Zhongguo Zhen Jiu; 2022 Sep; 42(9):1011-6. PubMed ID: 36075597
[TBL] [Abstract][Full Text] [Related]
5. Berberine Alleviates Amyloid-beta Pathogenesis Via Activating LKB1/AMPK Signaling in the Brain of APP/PS1 Transgenic Mice.
Cai ZY; Wang CL; Lu TT; Yang WM
Curr Mol Med; 2019; 19(5):342-348. PubMed ID: 30873920
[TBL] [Abstract][Full Text] [Related]
6. Shenzhiling oral liquid protects the myelin sheath against Alzheimer's disease through the PI3K/Akt-mTOR pathway.
Zheng M; Liu Z; Mana L; Qin G; Huang S; Gong Z; Tian M; He Y; Wang P
J Ethnopharmacol; 2021 Oct; 278():114264. PubMed ID: 34082015
[TBL] [Abstract][Full Text] [Related]
7. Thamnolia vermicularis extract improves learning ability in APP/PS1 transgenic mice by ameliorating both Aβ and Tau pathologies.
Li C; Guo XD; Lei M; Wu JY; Jin JZ; Shi XF; Zhu ZY; Rukachaisirikul V; Hu LH; Wen TQ; Shen X
Acta Pharmacol Sin; 2017 Jan; 38(1):9-28. PubMed ID: 27694908
[TBL] [Abstract][Full Text] [Related]
8. Small molecule LX2343 ameliorates cognitive deficits in AD model mice by targeting both amyloid β production and clearance.
Guo XD; Sun GL; Zhou TT; Xu X; Zhu ZY; Rukachaisirikul V; Hu LH; Shen X
Acta Pharmacol Sin; 2016 Sep; 37(10):1281-1297. PubMed ID: 27569389
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of PI3K/Akt/mTOR signaling pathway in curcumin-induced autophagy in APP/PS1 double transgenic mice.
Wang C; Zhang X; Teng Z; Zhang T; Li Y
Eur J Pharmacol; 2014 Oct; 740():312-20. PubMed ID: 25041840
[TBL] [Abstract][Full Text] [Related]
10. Berberine Improves Cognitive Impairment by Simultaneously Impacting Cerebral Blood Flow and β-Amyloid Accumulation in an APP/tau/PS1 Mouse Model of Alzheimer's Disease.
Ye C; Liang Y; Chen Y; Xiong Y; She Y; Zhong X; Chen H; Huang M
Cells; 2021 May; 10(5):. PubMed ID: 34064687
[TBL] [Abstract][Full Text] [Related]
11. Berberine attenuates cognitive impairment and ameliorates tau hyperphosphorylation by limiting the self-perpetuating pathogenic cycle between NF-κB signaling, oxidative stress and neuroinflammation.
He W; Wang C; Chen Y; He Y; Cai Z
Pharmacol Rep; 2017 Dec; 69(6):1341-1348. PubMed ID: 29132092
[TBL] [Abstract][Full Text] [Related]
12. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of p-mTOR represses transcription of PS1 and Notch 1-signaling.
Das HK; Hontiveros SS
Front Biosci (Landmark Ed); 2020 Mar; 25(6):1172-1183. PubMed ID: 32114428
[TBL] [Abstract][Full Text] [Related]
14. Berberine Ameliorates Cognitive Disorder via GSK3β/PGC-1α Signaling in APP/PS1 Mice.
Yang M; Wang J
J Nutr Sci Vitaminol (Tokyo); 2022; 68(3):228-235. PubMed ID: 35768254
[TBL] [Abstract][Full Text] [Related]
15. [Moxibustion at acpoints of governor vessel on regulating PI3K/Akt/mTOR signaling pathway and enhancing autophagy process in APP/PS1 double-transgenic Alzheimer's disease mice].
Zhang LD; Han W; Zhu CF; Song XG; Cheng H; Yang K; Qin XF; Zhang JY; Gui L
Zhongguo Zhen Jiu; 2019 Dec; 39(12):1313-8. PubMed ID: 31820607
[TBL] [Abstract][Full Text] [Related]
16. Geniposide effectively reverses cognitive impairment and inhibits pathological cerebral damage by regulating the mTOR Signal pathway in APP∕PS1 mice.
Zhang Z; Gao W; Wang X; Zhang D; Liu Y; Li L
Neurosci Lett; 2020 Feb; 720():134749. PubMed ID: 31935433
[TBL] [Abstract][Full Text] [Related]
17. Chlorogenic Acid Alleviates Aβ
Gao L; Li X; Meng S; Ma T; Wan L; Xu S
Drug Des Devel Ther; 2020; 14():1705-1716. PubMed ID: 32440096
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro.
Ding B; Lin C; Liu Q; He Y; Ruganzu JB; Jin H; Peng X; Ji S; Ma Y; Yang W
J Neuroinflammation; 2020 Oct; 17(1):302. PubMed ID: 33054814
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin Ameliorates Cognitive Impairments and Alzheimer's Disease-Like Pathology with Restoring Mitochondrial Abnormality in the Hippocampus of Streptozotocin-Induced Diabetic Mice.
Ding Y; Liu H; Cen M; Tao Y; Lai C; Tang Z
Neurochem Res; 2021 Feb; 46(2):265-275. PubMed ID: 33140268
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of NLRP1 inflammasome improves autophagy dysfunction and Aβ disposition in APP/PS1 mice.
Li X; Zhang H; Yang L; Dong X; Han Y; Su Y; Li W; Li W
Behav Brain Funct; 2023 Apr; 19(1):7. PubMed ID: 37055801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]